James W. Duke, Pharm.D.Promoted to Chief Clinical Officer; Joseph Gruber, R.Ph. Takes New Role as Senior Vice President of Product Solutions
Tallahassee -- February 11, 2026 - ActualMeds, the industry leader in patient-centered medication management, today announced the promotion of James W. Duke, Pharm.D.to Chief Clinical Officer and the appointment of Joseph Gruber, R.Ph. to the newly created role of Senior Vice President of Product Solutions. These strategic leadership changes help position the company to further accelerate clinical innovation and expand market growth.
As Chief Clinical Officer, Duke will spearhead initiatives to bring ActualMeds’ rules framework to the next level of agentic AI to facilitate workflows and scalability with the highest standards of clinical quality. His efforts will also focus on continuing to actively participate and contribute to industry standards bodies like Pharmacy Quality Alliance (PQA) and the PACIO Project for Interoperability.
Duke brings over 30 years of diverse pharmacy experience spanning long-term care consulting, hematology-oncology clinical services, and retail pharmacy. He holds a Doctorate of Pharmacy from Mercer University Southern School of Pharmacy and a B.A. in Chemistry from Huntingdon College.
"I am excited to lead and support innovation in transition of care medication management by blending advanced technology with pharmacist-led, patient-centered care. I look forward to continuing to collaborate with our experienced team to transform medication reconciliation into an even more seamless, outcomes-focused process across the continuum,” said Duke.
With Duke stepping into the Chief Clinical Officer role, Gruber will become the Senior Vice President of Product Solutions, a new role focused on growth initiatives. In this capacity, he will lead efforts to leverage ActualMeds’ platform interoperability, tech-enabled services, and virtual business models to connect use cases across settings of care – an important focus as the market evolves rapidly towards delivering high-quality care with superior outcomes in the lowest cost settings like the home.
Gruber has been with ActualMeds since 2013 and brings extensive experience from his 20-year career with CVS/Omnicare LTC Pharmacy, where he served in leadership roles including National Director of Medication Management Services. He holds a BS Pharm from St. Louis College of Pharmacy and Master's Certification in Gerontology from Southern Illinois University.
“This new role allows me to help bring ActualMeds' expertise to new customers and use cases that deeply need our team and technology," said Gruber. "With the release of our new InConcert4.0 medication management system, we can power the efficient and robust management of a patient's medications regardless of age, condition, and care setting which is critical to the industry now more than ever before.”
Emily Schmitz, Pharm.D, CEO of ActualMeds added,"James and Joseph have been instrumental in building ActualMeds into the market leader we are today. Their ongoing commitment to our mission of patient-centered medication management has helped drive our success. These new roles enable both leaders to apply their deep expertise where it matters most for our company and those we serve."
For more information, contact ActualMeds at https://www.actualmeds.com/contact.
About ActualMeds:
For more than a decade, ActualMeds has paved the way in automating clinical best practices for comprehensive medication review and medication reconciliation. The company brings a wealth of subject matter expertise in interoperability, artificial intelligence, and robotic process automation as well as deep clinical expertise to create seamless medication management for patients and their care teams across all post-acute care settings The innovative platform with highly structured, precise protocols drives scalable high-touch interactions that result in meaningful patient engagement, elimination of barriers, and problem resolution to and to promote adherence and reduce hospitalization and re-admissions for high risk patients. Healthcare organizations can become more efficient, increase access to quality care, and deliver better outcomes for themselves, and their patients with the support of the company’s technology-enabled solutions. Learn more at www.actualmeds.com today.
